Builder Investment Group’s Pfizer PFE Stock Holding History

Builder Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Hold	10,910	–	–	0.05%	96
2026 Q1	$306K	Hold	10,910	–	–	0.07%	87
2025 Q4	$272K	Hold	10,910	–	–	0.06%	91
2025 Q3	$278K	Sell	10,910 -240	-2%	-$5.92K	0.06%	88
2025 Q2	$270K	Hold	11,150	–	–	0.07%	88
2025 Q1	$283K	Hold	11,150	–	–	0.08%	84
2024 Q4	$296K	Sell	11,150 -264	-2%	-$7.16K	0.08%	82
2024 Q3	$330K	Sell	11,414 -889	-7%	-$25.9K	0.09%	77
2024 Q2	$344K	Buy	12,303 +7	+0.1%	+$193	0.09%	74
2024 Q1	$341K	Sell	12,296 -236	-2%	-$6.55K	0.1%	75
2023 Q4	$361K	Sell	12,532 -1,419	-10%	-$42.9K	0.13%	73
2023 Q3	$463K	Hold	13,951	–	–	0.18%	62
2023 Q2	$512K	Sell	13,951 -5	-0%	-$195	0.2%	58
2023 Q1	$569K	Hold	13,956	–	–	0.25%	53
2022 Q4	$715K	Buy	+13,956	New	+$669K	0.34%	48

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

Builder Investment Group's PFE Position: Q2 2026 in Review

Builder Investment Group held its Pfizer (PFE) position steady in Q2 2026 at 10,910 shares worth $263K. The position accounts for 0.05% of the portfolio, ranked #96.

Builder Investment Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $715K in Q4 2022. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Builder Investment Group held 10,910 shares of Pfizer worth $263K as of Q2 2026.
Builder Investment Group left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.05% of Builder Investment Group's portfolio in Q2 2026, its #96 holding.
Builder Investment Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Builder Investment Group's Pfizer position peaked at $715K in Q4 2022.
632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Builder Investment Group's 13F filing for Q2 2026, filed 17 Jul 2026.